Description

2-Chloro-7-Methyl-3-(5-Methyl-1,2,4-Oxadiazol-3-Yl)Quinoline is a high-purity, advanced pharmaceutical intermediate with a complex heterocyclic structure. This compound is valued for its role as a key building block in the synthesis of novel active pharmaceutical ingredients (APIs), particularly in therapeutic areas requiring targeted molecular scaffolds. It is primarily utilized by research institutions and pharmaceutical manufacturers engaged in drug discovery and development programs. The product is supplied with a focus on batch-to-batch consistency and reliable purity to support critical R&D and scale-up processes.

Application

• Pharmaceutical Intermediate: Serves as a critical precursor in the synthesis of novel drug candidates, especially in oncology and central nervous system (CNS) therapeutic research.
• Medicinal Chemistry Research: Used as a versatile scaffold for structure-activity relationship (SAR) studies and library synthesis in early-stage drug discovery.
• Agrochemical Development: Potential application as an intermediate in the research and development of new crop protection agents and pesticides.
• Organic Synthesis Building Block: Employed in academic and industrial laboratories for constructing complex quinoline-oxadiazole hybrid molecules.
• Biochemical Tool Compound: May be used in biochemical assays to study enzyme inhibition or receptor binding mechanisms.
• Material Science Research: Investigated for potential use in the development of organic electronic materials due to its conjugated system.

Basic Information

Item	Details
Product Name	2-Chloro-7-Methyl-3-(5-Methyl-1,2,4-Oxadiazol-3-Yl)Quinoline
CAS No.	1142201-75-9
Molecular Formula	C₁₄H₁₀ClN₃O
Molecular Weight	271.70 g/mol
Synonyms	2-Chloro-7-methyl-3-(5-methyl-1,2,4-oxadiazol-3-yl)quinoline; 3-(2-Chloro-7-methylquinolin-3-yl)-5-methyl-1,2,4-oxadiazole; Quinoline, 2-chloro-7-methyl-3-(5-methyl-1,2,4-oxadiazol-3-yl)-; CAS 1142201-75-9
EINECS	Contact for details

Quality Control

Our 2-Chloro-7-Methyl-3-(5-Methyl-1,2,4-Oxadiazol-3-Yl)Quinoline is manufactured under a strict quality management system. Each batch undergoes comprehensive analytical testing, including HPLC for purity and identity confirmation via spectroscopic methods, to ensure it meets the high standards required for pharmaceutical research. Certificates of Analysis (COA) detailing all test results are provided and available upon request to support your regulatory and quality assurance needs.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, and well-ventilated place at a controlled room temperature (15-25°C). Due to its hygroscopic (moisture-sensitive) nature, the container must be kept tightly sealed after opening to prevent degradation from atmospheric moisture.

Specification

Item	Specification
Appearance	White to off-white powder
Identification (HPLC/IR)	Conforms to reference standard
Assay (HPLC)	≥ 98.0%
Related Substances (HPLC)	Total impurities ≤ 2.0%
Water Content (KF)	≤ 0.5%
Residue on Ignition	≤ 0.1%

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.